AbCellera Biologics (ABCL) Insider Trading & Ownership → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free ABCL Stock Alerts $4.04 -0.04 (-0.98%) (As of 05/30/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AbCellera Biologics (NASDAQ:ABCL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage32.45%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$23.33 MNumber OfInsiders Selling(Last 3 Years)6Amount OfInsider Selling(Last 3 Years)$340.72 M Get ABCL Insider Trade Alerts Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABCL Insider Buying and Selling by Quarter Ad Chaikin AnalyticsBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. AbCellera Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/26/2023Andrew BoothCFOBuy14,500$6.85$99,325.00 5/26/2023Holdings Ltd. ThermopylaeMajor ShareholderBuy153,000$6.52$997,560.00 12/16/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy85,102$10.10$859,530.20 8/19/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy200,000$11.46$2,292,000.00 6/13/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy54,915$8.03$440,967.45 6/6/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy64,545$7.50$484,087.50 Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company5/16/2022Veronique LecaultCOOBuy200,000$6.34$1,268,000.00 5/12/2022Andrew BoothCFOBuy85,000$5.79$492,150.00 5/12/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy1,408,468$6.41$9,028,279.88 3/4/2022John S MontalbanoDirectorBuy10,000$8.54$85,400.00 3/1/2022John S MontalbanoDirectorBuy20,000$9.05$181,000.00 2/28/2022Veronique LecaultCOOBuy230,789$8.66$1,998,632.74 12/3/2021Andrew LoDirectorBuy86,938$14.02$1,218,870.76 11/11/2021Andrew BoothCFOBuy53,500$14.74$788,590.00 11/11/2021Holdings Ltd. ThermopylaeMajor ShareholderBuy202,960$14.76$2,995,689.60 8/31/2021John HamerDirectorSell162,649$16.95$2,756,900.55 8/16/2021John S MontalbanoDirectorBuy6,000$17.23$103,380.00 6/22/2021Michael R HaydenDirectorSell100,000$25.50$2,550,000.00 6/9/2021Andrew BoothCFOSell1,200,000$25.50$30,600,000.00 6/9/2021Carl L G HansenCEOSell6,000,000$24.13$144,780,000.00 6/9/2021Holdings Ltd. ThermopylaeMajor ShareholderSell5,598,420$24.03$134,530,032.60 6/9/2021Veronique LecaultCOOSell1,000,000$25.50$25,500,000.00 (Data available from 1/1/2013 forward) ABCL Insider Trading Activity - Frequently Asked Questions Who is on AbCellera Biologics's Insider Roster? The list of insiders at AbCellera Biologics includes Andrew Booth, Andrew Lo, Carl L G Hansen, Holdings Ltd. Thermopylae, John Hamer, John S Montalbano, Michael R Hayden, and Veronique Lecault. Learn more on insiders at ABCL. What percentage of AbCellera Biologics stock is owned by insiders? 32.45% of AbCellera Biologics stock is owned by insiders. Learn more on ABCL's insider holdings. Which AbCellera Biologics insiders have been buying company stock? The following insiders have purchased ABCL shares in the last 24 months: Andrew Booth ($99,325.00), and Holdings Ltd. Thermopylae ($5,074,145.15). How much insider buying is happening at AbCellera Biologics? Insiders have purchased a total of 572,062 ABCL shares in the last 24 months for a total of $5,173,470.15 bought. More Insider Trading Tools from MarketBeat Related Companies: ALPN Insider Ownership NUVL Insider Ownership ALKS Insider Ownership PRGO Insider Ownership CRNX Insider Ownership AXSM Insider Ownership MRUS Insider Ownership RARE Insider Ownership INSM Insider Ownership BHVN Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:ABCL) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon Musk’s Final Masterpiece: “X-9840”Paradigm PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.